
Cardiovascular Systems CSII
Cardiovascular Systems Total Shareholders Equity | CSII
Annual Total Shareholders Equity Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 249 M | 271 M | 269 M | 148 M | 134 M | 118 M | 101 M | 139 M | 152 M | 66.8 M | 32.2 M | 21.6 M | 17.7 M | 30.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 271 M | 17.7 M | 125 M |
Quarterly Total Shareholders Equity Cardiovascular Systems
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 239 M | 242 M | 239 M | 253 M | 260 M | 263 M | 260 M | 263 M | 270 M | 263 M | 274 M | 268 M | 143 M | 142 M | 143 M | 142 M | 139 M | 134 M | 139 M | 126 M | 124 M | 120 M | 124 M | 113 M | 112 M | 103 M | 112 M | 102 M | 121 M | 131 M | 121 M | 143 M | 148 M | 148 M | 148 M | 156 M | 156 M | 65.3 M | 156 M | 70 M | 29.2 M | 29 M | 29.2 M | 19.3 M | 21.9 M | 23.3 M | 21.9 M | 23.3 M | 21.6 M | 21.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 274 M | 19.3 M | 138 M |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
40.9 M | - | - | $ 162 M | ||
|
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
638 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
LENSAR
LNSR
|
-26 M | $ 5.6 | -2.78 % | $ 67 M | ||
|
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | ||
|
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | ||
|
Outset Medical
OM
|
127 M | $ 4.04 | -4.49 % | $ 61.5 K | ||
|
AxoGen
AXGN
|
129 M | $ 39.49 | -0.6 % | $ 1.82 B | ||
|
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | ||
|
Insulet Corporation
PODD
|
1.52 B | $ 163.26 | 3.08 % | $ 11.5 B | ||
|
Quanterix Corporation
QTRX
|
296 M | $ 3.67 | -6.38 % | $ 156 M | ||
|
Bruker Corporation
BRKR
|
2.46 B | $ 60.45 | -2.74 % | $ 9.18 B | ||
|
Sintx Technologies
SINT
|
2.93 M | $ 1.42 | -6.58 % | $ 3.94 M | ||
|
TELA Bio
TELA
|
6.31 M | $ 0.69 | -2.81 % | $ 32.4 M | ||
|
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | ||
|
Tactile Systems Technology
TCMD
|
219 M | $ 27.48 | 0.15 % | $ 629 M | ||
|
TransMedics Group
TMDX
|
473 M | $ 72.26 | 1.59 % | $ 2.46 B | ||
|
IRIDEX Corporation
IRIX
|
4.92 M | $ 0.89 | -3.38 % | $ 15.1 M | ||
|
Tandem Diabetes Care
TNDM
|
155 M | $ 17.12 | 1.3 % | $ 1.16 B | ||
|
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | ||
|
ClearPoint Neuro
CLPT
|
28 M | $ 14.12 | -2.55 % | $ 400 M | ||
|
Viemed Healthcare
VMD
|
142 M | $ 11.77 | 0.86 % | $ 458 M | ||
|
Avanos Medical
AVNS
|
778 M | $ 24.99 | 0.04 % | $ 1.16 B | ||
|
Beyond Air
XAIR
|
6.13 M | $ 5.16 | -5.67 % | $ 42.8 B | ||
|
Invacare Corporation
IVC
|
81.1 M | - | - | $ 24.7 M | ||
|
Xtant Medical Holdings
XTNT
|
51 M | $ 0.43 | -0.39 % | $ 60 M | ||
|
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.36 | -0.39 % | $ 22.4 M | ||
|
NanoVibronix
NAOV
|
33.5 M | - | - | $ 1.08 M | ||
|
NuVasive
NUVA
|
869 M | - | - | $ 2.07 B | ||
|
Natus Medical Incorporated
NTUS
|
425 M | - | 1.94 % | $ 1.05 B | ||
|
Nevro Corp.
NVRO
|
231 M | - | - | $ 217 M | ||
|
Inogen
INGN
|
192 M | $ 6.15 | -2.69 % | $ 164 M |